Trial Profile
Efficacy and safety of vitamin K + lenvatinib combination treatment against hepatocellular carcinoma:a randomised,open label,phase 2 trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2018
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary) ; Vitamin K (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 22 Jun 2018 New trial record